Protective Effect of Aspirin on COVID-19 Patients

Clinical trial NCT04365309 · UNKNOWN

Trial details

NCT number: NCT04365309
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Novel Coronavirus Pneumonia Aspirin Treatment

Start date: 2020-02-10
Primary completion: 2020-04-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.